Literature DB >> 7895494

Gp130 in human myeloma/plasmacytoma.

Y Tani1, N Nishimoto, A Ogata, Y Shima, K Yoshizaki, T Kishimoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7895494     DOI： 10.1007/978-3-642-79275-5_27

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  2 in total

1.  Janus kinase inhibitor INCB20 has antiproliferative and apoptotic effects on human myeloma cells in vitro and in vivo.

Authors:  Renate Burger; Steven Le Gouill; Yu-Tzu Tai; Reshma Shringarpure; Pierfrancesco Tassone; Paola Neri; Klaus Podar; Laurence Catley; Teru Hideshima; Dharminder Chauhan; Eian Caulder; Claire L Neilan; Kris Vaddi; Jun Li; Martin Gramatzki; Jordan S Fridman; Kenneth C Anderson
Journal:  Mol Cancer Ther       Date:  2009-01       Impact factor: 6.261

2.  Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications.

Authors:  Constantine S Mitsiades; Nicholas S Mitsiades; Ciaran J McMullan; Vassiliki Poulaki; Reshma Shringarpure; Teru Hideshima; Masaharu Akiyama; Dharminder Chauhan; Nikhil Munshi; Xuesong Gu; Charles Bailey; Marie Joseph; Towia A Libermann; Victoria M Richon; Paul A Marks; Kenneth C Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-26       Impact factor: 11.205
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.